Thyroid and the eye

Current Opinion in Ophthalmology

Volumn 13, Issue 6, 2002, Pages 352-356

  Chavis, Pamela Suzanne ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BOTULINUM TOXIN A; CD40 ANTIGEN; GAMMA INTERFERON; GLUCOCORTICOID; GLYCOSAMINOGLYCAN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; OCTREOTIDE; PREDNISONE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR; TRIAMCINOLONE; TROPOMODULIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

COMPUTER ASSISTED TOMOGRAPHY; DIPLOPIA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE DISEASE; EYELID RETRACTION; GRAVES DISEASE; HUMAN; INTRAOCULAR HYPERTENSION; KERATOCONJUNCTIVITIS; LAGOPHTHALMOS; METASTASIS; MYXEDEMA; NERVE DECOMPRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PRIORITY JOURNAL; REVIEW; SMOKING; TH1 CELL; TH2 CELL; THYROID CANCER; THYROID DISEASE; UVEA TUMOR;

DECOMPRESSION, SURGICAL; DIPLOPIA; GLUCOCORTICOIDS; GRAVES DISEASE; HUMANS; RECURRENCE; RISK FACTORS; SMOKING;

EID: 0036893338     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200212000-00002     Document Type: Review

References (54)

1. Ahmadi MA, Nicholes D, Esmaeli B: Late choroidal metastasis secondary to papillary thyroid carcinoma. Am J Ophthalmol 2001, 132:796-798.
2. Jacobs JM, Hawes MJ: From eyelid bumps to thyroid lumps. Ophthal Plast Reconstr Surg 2001, 17:195-201.
3. Eter N, Klingmuller D, Hoppner W, Spitznas M: Typical ocular findings in a patient with multiple endocrine neoplasia type 2b syndrome. Graefes Arch Clin Exp Ophthalmol 2001, 239:391-394.
4. Dickinson AJ, Perros P: Controversies in the clinical evaluation of active thyroid-associated orbitopathy. Clin Endocrinol 2001, 55:283-303.
5. Ohtsuka K, Nakamura Y: Author Reply: Open Angle Glaucoma Associated with Graves Disease 2002, 133:292-293.
6. Mayer E, Herdman G, Burnett C, et al: Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid disease. Eye 2001, 15:313-318.
7. Nishida Y, Tian S, Isberg B, et al: MRI measurements of orbital tissues in dysthyroid ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 2001, 239:824-831.
8. Giaconi JA, Kazim M, Rho T, Pfaff C: CT evidence of dysthyroid optic neuropathy. Ophthal Plast Reconstr Surg 2002, 18:177-182.
9. Kahaly GJ: Imaging in Thyroid-Associated Orbitopathy 2001, 145:107-118.
10. Ebner R, Devoto M, Weil D, et al: Tratamiento de la oftalmopatia asociada a distiroidismo con triamcinolona periocular. Arch Oftalmol Bs As 2001, 76:55-66.
11. Marcocci C, Bartalena L, Tanda ML, et al: Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy. J Clin Endocrinol Metab 2001, 86:3562-3567.
12. Marquez SD, Lum BL, McDougall IR, et al: Long-term results of irradiation for patients with progressive Graves' ophthalmopathy. Int J Rad Oncol Biol Phys 2001, 51:766-774.
13. Wiersinga WM: Respective-Part III. Ophthal Plast Reconstr Surg 2002, 18:175-176.
14. Gorman CA, Garrity JA, Fatourechi V, et al: A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmol 2001, 108:1523-1534.
15. Kazim M: Perspective - Part II: Radiotherapy for Graves' orbitopathy. Ophthal Plast Reconstr Surg 2002, 18:173-174.
16. Feldon SE: Editorial: Radiation therapy for Graves' ophthalmopathy. Ophthalmol 2001, 108:1521-1522.
17. Mourits MP: Does radiotherapy have a role in the management of thyroid orbitopathy? Br J Ophthalmol 2002, 86:104-106.
18. Kahaly GJ, Rosler HP, Pitz S, et al: Radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 2001, 86:2327-2328.
19. May A, Zubcov A, Fries U, et al: Ancillary procedures in microscopic endonasal orbital decompression for thyroid-associated ophthalmopathy. ORL 2001, 63:137-140.
20. Abramoff MD, Kalmann R, deGraaf MEL, et al: Rectus extraocular muscle paths and decompression surgery for Graves orbitopathy. IOVS 2002, 43:300-307.
21. Korinth MC, Ince A, Banghard W, Gilsbach JM: Clinical articles follow-up of extended pterional orbital decompression on severe Graves' orbitopathy. Acta Neurochir 2002, 144:113-120.
22. Diez JJ: Therapy of Graves' ophthalmopathy. Expert Opin Pharmacother 2001, 2:1361-1365.
23. Guerra LN, Moiguer S, Karner M, et al: Antioxidants in the Treatment of Graves Disease 2001, 51:105-109.
24. Traisk F, Tallstedt L: Thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 2001, 79:585-589.
25. Uddin JM, Davies P: Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival Botulinum toxin injection. Ophthalmol 2002, 109:1183-1187.
26. Nguyen VT, Park DJJ, Levin L, et al: Correction of restricted extraocular muscle motility in surgical management of strabismus in Graves' ophthalmopathy. Ophthalmol 2002, 109:384-388.
27. Gupta MR, Perl J, Beham R, et al: Effect of 131 iodine therapy on the course of Graves' ophthalmopathy. Thyroid 2001, 11:959-965.
28. Kurihara H: Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy. Thyroid 2002, 12:265-267.
29. Jyonouchi SC, Valyasevi RW, Harteneck DA, et al: Interleukin-6 stimulates thyrotropin receptor expression in human preadipocyte fibroblasts from patients with Graves' ophthalmopathy. Thyroid 2001, 11:929-934.
30. Kazim M, Goldberg RA, Smith TJ: Insights into the pathogenesis of thyroid-associated ophthalmopathy. Arch Ophthalmol 2002, 120:380-386.
31. Smith TJ, Koumas L, Gagnon A, et al: Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 2002, 87:385-392.
32. Heufelder A: Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disorders 2000, 1:87-90.
33. Koumas L, Smith TJ, Phipps RP: Fibroblast subsets in the human orbit. Eur J Immunol 2002, 32:477-485.
34. Ludgate M, Baker G: Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol 2002, 127:193-198.
35. Pritchard J, Horst N, Cruikshank W, et al: IGs from patients with Graves' induce the expression of T cell chemoattractants in their fibroblasts. J Immunol 2002, 168:942-950.
36. Vestergaard P: Smoking and thyroid disorders: A meta-analysis. Eur J Endocrinol 2002, 146:153-161.
37. Kimball L, Kulinskaya E, Brown B, et al: Does smoking increase relapse rate in Graves disease? J Endocrinol Invest 2002, 25:152-157.
38. Mysliwiec J, Kretowski A, Topolska J, et al: Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids. Horm Metab Res 2001, 33:739-743.
39. Tanwani LK, Lohano V, Ewart R, et al: Myasthenia gravis in conjunction with Graves' disease. Endocr Pract 2001, 7:275-278.
40. Selva-O'Callaghan A, Mijares-Boeckh-Behrens T, Solans-Laque R, et al: Dermatomyositis with Graves' disease. Clin Exp Rheumatol 2001, 19:595-596.
41. Polizzi A, Ruggieri M, Vecchio I, et al: Autoimmune thyroiditis and acquired demyelinating polyradiculoneuropathy. Clin Neurol Neurosurg 2001, 103:151-154.
42. Guma M, Olive A, Juan M, Salinas I: ANCA antibodies in Graves' disease. Ann Rheum Dis 2002, 61:90-1.
43. Bonapace ES, Srinivasan R: Simultaneous occurrence of inflammatory bowel disease and thyroid disease. Am J Gastroenterol 2001, 96:1925-1926.
44. Ogard CG, Ogard C, Almdal TP: Thyroid-associated orbitopathy developed during hormone replacement therapy. Acta Ophthalmol Scand 2001, 79:426-427.
45. Marga M, Denisova A, Sochnev A, et al: Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves' disease. Am J Med Genet 2001, 102:188-191.
46. Kawame H, Adachi M, Tachibana K, et al: Graves' disease in patients with 22q11.2 deletion. J Pediatr 2001, 139:892-895.
47. Daumerie C, Ludgate M, Costagliola S, et al: Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol 2002, 146:35-38.
48. Schwartz KM, Fatourechi V, Ahmed DDF, et al: Dermatopathy of Graves' disease (pretibial myxedema). J Clin Endocrinol Metab 2002, 87:438-446.
49. Busuttil BE, Frauman AG: Extrathyroidal manifestations of Graves' disease. J Clin Endocrinol Metab 2001, 86:2315-2319.
50. Vanhoenacker FM, Pelckmans MC, DeBeuckeleer LH, et al: Thyroid acropachy. Eur Radiol 2001, 11:1058-1062.
51. Miller KK, Daniels GH: Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin Endocrinol 2001, 55:501-508.
52. Roti E, Uberti ED: Iodine excess and hyperthyroidism. Thyroid 2001, 11:493-500.
53. Matos-Santos A, Nobre EL, Costa JGE, et al: Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goiter. Clin Endocrinol 2001, 55:15-19.
54. Pijl H, deMeijer PHEM, Langius J, et al: Food choice in hyperthyroidism. J Clin Endocrinol Metab 2001, 86:5848-5853.